# EXOme Rare Cancers in Children (EXOCARE)

> **NCT03472807** · NA · TERMINATED · sponsor: **University Hospital, Angers** · enrollment: 169 (actual)

## Conditions studied

- Predisposition, Genetic
- Cancer Childhood
- Development Delay

## Interventions

- **OTHER:** Collection of blood sample or saliva
- **OTHER:** Collection of a tumor sample taken before the participation of the patient in study
- **OTHER:** Collection of blood sample if tumor sample is not available

## Key facts

- **NCT ID:** NCT03472807
- **Lead sponsor:** University Hospital, Angers
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-11-13
- **Primary completion:** 2024-02-22
- **Final completion:** 2024-02-22
- **Target enrollment:** 169 (ACTUAL)
- **Why stopped:** Inclusions stopped due to lack of inclusions
- **Last updated:** 2025-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03472807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03472807, "EXOme Rare Cancers in Children (EXOCARE)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03472807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*